Status:
WITHDRAWN
Predictors of Drug Hypersensitivity in HIV Infected Subjects
Lead Sponsor:
The Alfred
Collaborating Sponsors:
National Health and Medical Research Council, Australia
Monash University
Conditions:
HIV Infections
Hypersensitivity
Eligibility:
All Genders
18+ years
Brief Summary
A case-control study to look at hypersensitive and tolerant individuals matched for HLA genetic predisposition, when considering predictors of drug hypersensitivity.The study aims to identify the immu...
Detailed Description
1. To determine in a case control study clinical parameters associated with drug HSR to abacavir, nevirapine and efavirenz in HIV infected subjects. 2. To measure functional and numerical differences ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- HIV infected patients on treatment with the drugs Efavirenz, Nevirapine, or Abacavir.
- Age over 18 Cases are those who have had a hypersensitivity reaction, and controls are those who have had no reaction
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00168220
Start Date
August 1 2005
Last Update
January 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3004